Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
14
Warrant Exposure
90
Convertible Debt
35
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 65%
• 50-day avg $0.01 below $1 exchange minimum
• 9 months cash with weak price
📜 Warrant Exercise
model 60%
• Massive warrant overhang: 198% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise
model 15%
• Under 12 months cash (9mo)
Market Data
Market Cap$927.7K
Shares Outstanding132.53M
Float132.53M
Cash$1.49M
Debt$4.00M
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest390
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual EVFM Dilution Snapshot
Evofem Biosciences, Inc. (EVFM) has a DilutionScore of 55/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 263.1M.
- Recent SEC activity tracked for EVFM: xbrl on 2026-06-30; xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: